Homocysteine, cognition and brain white matter hyperintensities

Acta Neurologica Taiwanica

Volumn 19, Issue 3, 2010, Pages 150-152

  Fuh, Jong Ling ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE;

ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; EDITORIAL; EMBASE; ENDOTHELIUM CELL; HUMAN; HYPERHOMOCYSTEINEMIA; MEDLINE; META ANALYSIS (TOPIC); MYELINATION; NUCLEAR MAGNETIC RESONANCE; PROTEIN METHYLATION; PSYCINFO; RISK FACTOR; TAIWAN; THROMBOEMBOLISM; WHITE MATTER; BRAIN; BRAIN DISEASE; METABOLISM; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRAIN; BRAIN DISEASES; COGNITION; HOMOCYSTEINE; HUMANS; NERVE FIBERS;

EID: 79952456924     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Newton LA, Sandhu K, Livingstone C, Leslie R, Davis J. Clinical diagnostics for homocysteine: a rogue amino acid? Expert Rev Mol Diagn 2010;10:489-500.
2. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698.
3. Sachdev PS. Homocysteine and brain atrophy. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1152-1161.
4. Van Dam F, Van Gool WA. Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr 2009;48:425-430.
5. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Lúis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775-1781.
6. Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother 2009;9:1393-1412.
7. Tu MC, Huang CW, Chen NC, Chang WN, Lui CC, Chen CF. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurological Taiwanica 2010. Acta Neurol Taiwan 2010;19:164-173.
8. Ariogul S, Cankurtaran M, Dagli N, Khalil M, Yavuz B. Vitamin B12, folate, homocysteine and dementia: are they really related? Arch Gerontol Geriatr 2005;40:139-146.
9. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540-546.
10. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007;85:511-517.
11. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RG, de Craen AJ. Homocysteine, vitamin B12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am J Clin Nutr 2005;82:866-871.
12. Seshadri S. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 2006;9:393-398.
13. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
14. Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, Den Bosch MA, Kemmeren JM. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration. Eur J Clin Invest 2002;32:549-555.
15. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002;31:59-70.
16. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systemic review and meta-analysis. Mayo Clin Proc 2008;83:1203-1212.
17. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from Mendelian randomization Lancet 2006;365:224-232.
18. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817.
19. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410-414.
20. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL. Total homocysteine is associated with white matter hyperintensity volume: The Northern Manhattan Study. Stroke 2005;36:1207-1211.
21. Huang CW, Chang WN, Lui CC, Chen CF, Lu CH, Wang YL, Chen C. Impacts of Hyper-Homocysteinemia and White Matter Hyper-intensity in Alzheimer's Disease Patients with Normal Creatinine: An MRI-Based Study with Longitudinal Follow-Up. Curr Alzheimer Res 2010;7:527-533.
22. Dufouil C, Alpérovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-221.
23. Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003;8:7-19.
24. Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kolsch H, Frommann I, Kornhuber J, Maier W, Jessen F. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis 2009;18,819-828.
25. Chang PY, Lu SC, Chen CH. S-adenosylhomocysteine: a better marker of the development of Alzheimer's disease than homocysteine? J Alzheimers Dis 2010;21:65-66.
26. Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of FGF2 involving G protein and DNA methylation. Circ Res 2008;102,933-941.
27. Ciaccio M, Bellia C. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction. Curr Clin Pharmacol 2010;5:30-36.